Comparative in vitro treatment of mesenchymal stromal cells with GDF-5 and R57A induces chondrogenic differentiation while limiting chondrogenic hypertrophy.
Bone marrow
Cartilage
Chondrogenesis
Chondrogenic hypertrophy
GDF-5
Mesenchymal stromal cell
R57A
Journal
Journal of experimental orthopaedics
ISSN: 2197-1153
Titre abrégé: J Exp Orthop
Pays: Germany
ID NLM: 101653750
Informations de publication
Date de publication:
21 Mar 2023
21 Mar 2023
Historique:
received:
28
12
2022
accepted:
08
03
2023
entrez:
21
3
2023
pubmed:
22
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
Hypertrophic cartilage is an important characteristic of osteoarthritis and can often be found in patients suffering from osteoarthritis. Although the exact pathomechanism remains poorly understood, hypertrophic de-differentiation of chondrocytes also poses a major challenge in the cell-based repair of hyaline cartilage using mesenchymal stromal cells (MSCs). While different members of the transforming growth factor beta (TGF-β) family have been shown to promote chondrogenesis in MSCs, the transition into a hypertrophic phenotype remains a problem. To further examine this topic we compared the effects of the transcription growth and differentiation factor 5 (GDF-5) and the mutant R57A on in vitro chondrogenesis in MSCs. Bone marrow-derived MSCs (BMSCs) were placed in pellet culture and in-cubated in chondrogenic differentiation medium containing R57A, GDF-5 and TGF-ß1 for 21 days. Chondrogenesis was examined histologically, immunohistochemically, through biochemical assays and by RT-qPCR regarding the expression of chondrogenic marker genes. Treatment of BMSCs with R57A led to a dose dependent induction of chondrogenesis in BMSCs. Biochemical assays also showed an elevated glycosaminoglycan (GAG) content and expression of chondrogenic marker genes in corresponding pellets. While treatment with R57A led to superior chondrogenic differentiation compared to treatment with the GDF-5 wild type and similar levels compared to incubation with TGF-ß1, levels of chondrogenic hypertrophy were lower after induction with R57A and the GDF-5 wild type. R57A is a stronger inducer of chondrogenesis in BMSCs than the GDF-5 wild type while leading to lower levels of chondrogenic hypertrophy in comparison with TGF-ß1.
Identifiants
pubmed: 36943593
doi: 10.1186/s40634-023-00594-z
pii: 10.1186/s40634-023-00594-z
pmc: PMC10030724
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29Informations de copyright
© 2023. The Author(s).
Références
Ayerst BI, Smith RA, Nurcombe V, Day AJ, Merry CL, Cool SM (2017) Growth differentiation factor 5-mediated enhancement of chondrocyte phenotype is inhibited by heparin: implications for the use of heparin in the clinic and in tissue engineering applications. Tissue Eng Part A 23:275–292
pubmed: 27899064
pmcid: 5397242
doi: 10.1089/ten.tea.2016.0364
Bai X, Xiao Z, Pan Y, Hu J, Pohl J, Wen J et al (2004) Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes. Biochem Biophys Res Commun 325:453–460
pubmed: 15530414
doi: 10.1016/j.bbrc.2004.10.055
Berebichez-Fridman R, Gomez-Garcia R, Granados-Montiel J, Berebichez-Fastlicht E, Olivos-Meza A, Granados J et al (2017) The holy grail of orthopedic surgery: mesenchymal stem cells-their current uses and potential applications. Stem Cells Int 2017:2638305
pubmed: 28698718
pmcid: 5494105
doi: 10.1155/2017/2638305
Brochhausen C, Lehmann M, Halstenberg S, Meurer A, Klaus G, Kirkpatrick CJ (2009) Signalling molecules and growth factors for tissue engineering of cartilage-what can we learn from the growth plate? J Tissue Eng Regen Med 3:416–429
pubmed: 19575393
doi: 10.1002/term.192
Cameron TL, Belluoccio D, Farlie PG, Brachvogel B, Bateman JF (2009) Global comparative transcriptome analysis of cartilage formation in vivo. BMC Dev Biol 9:20
pubmed: 19272164
pmcid: 2662817
doi: 10.1186/1471-213X-9-20
Cheng X, Yang T, Meng W, Liu H, Zhang T, Shi R (2012) Overexpression of GDF5 through an adenovirus vector stimulates osteogenesis of human mesenchymal stem cells in vitro and in vivo. Cells Tissues Organs 196:56–67
pubmed: 22287558
doi: 10.1159/000330791
Chubinskaya S, Segalite D, Pikovsky D, Hakimiyan AA, Rueger DC (2008) Effects induced by BMPS in cultures of human articular chondrocytes: comparative studies. Growth Factors 26:275–283
pubmed: 18651287
doi: 10.1080/08977190802291733
Coleman CM, Tuan RS (2003) Functional role of growth/differentiation factor 5 in chondrogenesis of limb mesenchymal cells. Mech Dev 120:823–836
pubmed: 12915232
doi: 10.1016/S0925-4773(03)00067-4
Coleman CM, Vaughan EE, Browe DC, Mooney E, Howard L, Barry F (2013) Growth differentiation factor-5 enhances in vitro mesenchymal stromal cell chondrogenesis and hypertrophy. Stem Cells Dev 22:1968–1976
pubmed: 23388029
pmcid: 3685316
doi: 10.1089/scd.2012.0282
De Bari C, Dell’Accio F, Luyten FP (2004) Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 50:142–150
pubmed: 14730610
doi: 10.1002/art.11450
Dickhut A, Pelttari K, Janicki P, Wagner W, Eckstein V, Egermann M et al (2009) Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol 219:219–226
pubmed: 19107842
doi: 10.1002/jcp.21673
Enochson L, Stenberg J, Brittberg M, Lindahl A (2014) GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition. Osteoarthritis Cartilage 22:566–577
pubmed: 24561281
doi: 10.1016/j.joca.2014.02.004
Evangelou E, Chapman K, Meulenbelt I, Karassa FB, Loughlin J, Carr A et al (2009) Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 60:1710–1721
pubmed: 19479880
pmcid: 4412885
doi: 10.1002/art.24524
Feng G, Wan Y, Balian G, Laurencin CT, Li X (2008) Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells. Growth Factors 26:132–142
pubmed: 18569021
pmcid: 3034080
doi: 10.1080/08977190802105917
Hellingman CA, Davidson EN, Koevoet W, Vitters EL, van den Berg WB, van Osch GJ et al (2011) Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 17:1157–1167
pubmed: 21142619
doi: 10.1089/ten.tea.2010.0043
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al (2005) Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 7:393–395
pubmed: 16236628
doi: 10.1080/14653240500319234
Iamthanaporn K, Chareancholvanich K, Pornrattanamaneewong C (2015) Revision primary total hip replacement: causes and risk factors. J Med Assoc Thai 98:93–99
pubmed: 25775739
Kania K, Colella F, Riemen AHK, Wang H, Howard KA, Aigner T et al (2020) Regulation of Gdf5 expression in joint remodelling, repair and osteoarthritis. Sci Rep 10:157
pubmed: 31932746
pmcid: 6957535
doi: 10.1038/s41598-019-57011-8
Klammert U, Mueller TD, Hellmann TV, Wuerzler KK, Kotzsch A, Schliermann A et al (2015) GDF-5 can act as a context-dependent BMP-2 antagonist. BMC Biol 13:77
pubmed: 26385096
pmcid: 4575486
doi: 10.1186/s12915-015-0183-8
Klug A, Gramlich Y, Rudert M, Drees P, Hoffmann R, Weißenberger M, et al. (2020) The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years. Knee Surg Sports Traumatol Arthrosc. https://doi.org/10.1007/s00167-020-06154-71-12
Kotzsch A, Nickel J, Sebald W, Mueller TD (2009) Purification, crystallization and preliminary data analysis of ligand-receptor complexes of growth and differentiation factor 5 (GDF5) and BMP receptor IB (BRIB). Acta Crystallogr Sect F Struct Biol Cryst Commun 65:779–783
pubmed: 19652338
pmcid: 2720332
doi: 10.1107/S1744309109024142
Lee DH, Lee SH, Song EK, Seon JK, Lim HA, Yang HY (2017) Causes and clinical outcomes of revision total knee arthroplasty. Knee Surg Relat Res 29:104–109
pubmed: 28545174
pmcid: 5450576
doi: 10.5792/ksrr.16.035
Li J, Dong S (2016) The signaling pathways involved in chondrocyte differentiation and hypertrophic differentiation. Stem Cells Int 2016:2470351
pubmed: 28074096
pmcid: 5198191
doi: 10.1155/2016/2470351
Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF (1998) Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415–428
pubmed: 9916173
doi: 10.1089/ten.1998.4.415
Mackie EJ, Tatarczuch L, Mirams M (2011) The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol 211:109–121
pubmed: 21642379
doi: 10.1530/JOE-11-0048
Mancuso P, Raman S, Glynn A, Barry F, Murphy JM (2019) Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Front Bioeng Biotechnol 7:9
pubmed: 30761298
pmcid: 6361779
doi: 10.3389/fbioe.2019.00009
Mang T, Kleinschmidt-Dörr K, Ploeger F, Lindemann S, Gigout A (2020) The GDF-5 mutant M1673 exerts robust anabolic and anti-catabolic effects in chondrocytes. J Cell Mol Med 24:7141–7150
pubmed: 32497388
pmcid: 7339174
doi: 10.1111/jcmm.15149
Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, Saito S et al (2007) A functional polymorphism in the 5’ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 39:529–533
pubmed: 17384641
doi: 10.1038/2005
Miyazono K (1999) Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25:91–93
pubmed: 10423029
doi: 10.1016/S8756-3282(99)00113-1
Mobasheri A, Csaki C, Clutterbuck AL, Rahmanzadeh M, Shakibaei M (2009) Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histopathol 24:347–366
pubmed: 19130405
Nickel J, Kotzsch A, Sebald W, Mueller TD (2011) Purification, crystallization and preliminary data analysis of the ligand-receptor complex of the growth and differentiation factor 5 variant R57A (GDF5R57A) and BMP receptor IA (BRIA). Acta Crystallogr Sect F Struct Biol Cryst Commun 67:551–555
pubmed: 21543859
pmcid: 3087638
doi: 10.1107/S1744309111006907
Nickel J, Kotzsch A, Sebald W, Mueller TD (2005) A single residue of GDF-5 defines binding specificity to BMP receptor IB. J Mol Biol 349:933–947
pubmed: 15890363
doi: 10.1016/j.jmb.2005.04.015
Noth U, Tuli R, Osyczka AM, Danielson KG, Tuan RS (2002) In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng 8:131–144
pubmed: 11886661
doi: 10.1089/107632702753503126
Oldershaw RA, Baxter MA, Lowe ET, Bates N, Grady LM, Soncin F et al (2010) Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol 28:1187–1194
pubmed: 20967028
doi: 10.1038/nbt.1683
Parrish WR, Byers BA, Su D, Geesin J, Herzberg U, Wadsworth S et al (2017) Intra-articular therapy with recombinant human GDF5 arrests disease progression and stimulates cartilage repair in the rat medial meniscus transection (MMT) model of osteoarthritis. Osteoarthritis Cartilage 25:554–560
pubmed: 27851984
doi: 10.1016/j.joca.2016.11.002
Reichert JC, Schmalzl J, Prager P, Gilbert F, Quent VM, Steinert AF et al (2013) Synergistic effect of Indian hedgehog and bone morphogenetic protein-2 gene transfer to increase the osteogenic potential of human mesenchymal stem cells. Stem Cell Res Ther 4:105
pubmed: 24004723
pmcid: 3854715
doi: 10.1186/scrt316
Reynard LN, Bui C, Syddall CM, Loughlin J (2014) CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383. Hum Genet 133:1059–1073
pubmed: 24861163
pmcid: 4099533
doi: 10.1007/s00439-014-1447-z
Scarfì S (2016) Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair. World J Stem Cells 8:1–12
pubmed: 26839636
pmcid: 4723717
doi: 10.4252/wjsc.v8.i1.1
Schreuder H, Liesum A, Pohl J, Kruse M, Koyama M (2005) Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites. Biochem Biophys Res Commun 329:1076–1086
pubmed: 15752764
doi: 10.1016/j.bbrc.2005.02.078
Seemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K et al (2005) Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest 115:2373–2381
pubmed: 16127465
pmcid: 1190374
doi: 10.1172/JCI25118
Sieker JT, Kunz M, Weissenberger M, Gilbert F, Frey S, Rudert M et al (2015) Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates. Osteoarthritis Cartilage 23:433–442
pubmed: 25463442
doi: 10.1016/j.joca.2014.11.008
Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Noth U (2007) Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 9:213
pubmed: 17561986
pmcid: 2206353
doi: 10.1186/ar2195
Steinert AF, Palmer GD, Pilapil C, Noth U, Evans CH, Ghivizzani SC (2009) Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A 15:1127–1139
pubmed: 18826340
doi: 10.1089/ten.tea.2007.0252
Steinert AF, Proffen B, Kunz M, Hendrich C, Ghivizzani SC, Noth U et al (2009) Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11:R148
pubmed: 19799789
pmcid: 2787261
doi: 10.1186/ar2822
Steinert AF, Weissenberger M, Kunz M, Gilbert F, Ghivizzani SC, Gobel S et al (2012) Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells. Arthritis Res Ther 14:R168
pubmed: 22817660
pmcid: 3580562
doi: 10.1186/ar3921
Sun K, Guo J, Yao X, Guo Z, Guo F (2021) Growth differentiation factor 5 in cartilage and osteoarthritis: a possible therapeutic candidate. Cell Prolif 54:e12998
pubmed: 33522652
pmcid: 7941218
doi: 10.1111/cpr.12998
Tian HT, Zhang B, Tian Q, Liu Y, Yang SH, Shao ZW (2013) Construction of self-assembled cartilage tissue from bone marrow mesenchymal stem cells induced by hypoxia combined with GDF-5. J Huazhong Univ Sci Technolog Med Sci 33:700–706
pubmed: 24142723
doi: 10.1007/s11596-013-1183-y
Venkatesan JK, Ekici M, Madry H, Schmitt G, Kohn D, Cucchiarini M (2012) SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells. Stem Cell Res Ther 3:22
pubmed: 22742415
pmcid: 3583131
doi: 10.1186/scrt113
Wagenbrenner M, Heinz T, Horas K, Jakuscheit A, Arnholdt J, Herrmann M et al (2020) The human arthritic hip joint is a source of mesenchymal stromal cells (MSCs) with extensive multipotent differentiation potential. BMC Musculoskelet Disord 21:297
pubmed: 32404085
pmcid: 7222515
doi: 10.1186/s12891-020-03340-z
Weber M, Renkawitz T, Voellner F, Craiovan B, Greimel F, Worlicek M et al (2018) Revision Surgery in Total Joint Replacement Is Cost-Intensive. Biomed Res Int 2018:8987104
pubmed: 30356391
pmcid: 6176320
doi: 10.1155/2018/8987104
Weissenberger M, Weissenberger MH, Gilbert F, Groll J, Evans CH, Steinert AF (2020) Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery. BMC Musculoskelet Disord 21:109
pubmed: 32066427
pmcid: 7026978
doi: 10.1186/s12891-020-3137-4
Weißenberger M, Weißenberger MH, Wagenbrenner M, Heinz T, Reboredo J, Holzapfel BM et al (2020) Different types of cartilage neotissue fabricated from collagen hydrogels and mesenchymal stromal cells via SOX9, TGFB1 or BMP2 gene transfer. PLoS ONE 15:e0237479
pubmed: 32790806
pmcid: 7425924
doi: 10.1371/journal.pone.0237479